Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Actinogen Medical Ltd
3ACCurrent price
0.018 EUR
+0.0055 EUR (+45.83%)
Last closed
0.024 AUD
Company
www.actinogen.com.au
ISIN
AU000000ACW3
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
73 163 511 AUD
Yield for 12 month
+11.04 %
1Y
3Y
5Y
10Y
15Y
3AC
Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials, that achieves target engagement in the brain for the treatment of Alzheimer's disease, major depressive disorder, fragile x syndrome, and other neurological diseases. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia. Address: 109 Pitt Street, Sydney, NSW, Australia, 2000
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.23 AUDP/E ratio
–Dividend Yield
–Current Year
+9 869 253 AUD
Last Year
+4 857 296 AUD
Current Quarter
+8 965 920 AUD
Last Quarter
+903 333 AUD
Current Year
+9 455 034 AUD
Last Year
+4 454 231 AUD
Current Quarter
+8 762 342 AUD
Last Quarter
+692 692 AUD
Key Figures 3AC
1 year
3 years
5 years
10 years
EBITDA
-12 840 179 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-45.37 %
PEG Ratio
–
Return On Equity TTM
-78.81 %
Wall Street Target Price
0.23 AUD
Revenue TTM
9 869 252 AUD
Book Value
0.007 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
132.3 %
Dividend Yield
–
Gross Profit TTM
4 857 297 AUD
Earnings per share
-0.0099 AUD
Diluted Eps TTM
-0.0099 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-131.34 %
Dividend Analytics 3AC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 3AC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:2
Payout Ratio
–
Last Split Date
03.12.2013
Dividend Date
–
Stock Valuation 3AC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
25.974
Enterprise Value Revenue
–
Price Sales TTM
7.4133
Enterprise Value EBITDA
-9.9502
Price Book MRQ
3.738
Financials 3AC
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 3AC
For 52 weeks
0.018 AUD
0.098 AUD
50 Day MA
0.03 AUD
Shares Short Prior Month
–
200 Day MA
0.037 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart